Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AXGN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 8.41 %
Consecutive Years 0
Forward Annual Dividend 1.00 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 27.01.2010

Axogen Inc

AXGN
Current price
11.89 USD -0.16 USD (-1.33%)
Last closed 12.05 USD
ISIN US05463X1063
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 562 339 776 USD
Yield for 12 month +37.30 %
1Y
3Y
5Y
10Y
15Y
AXGN
21.11.2021 - 28.11.2021

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida. Address: 13631 Progress Boulevard, Alachua, FL, United States, 32615

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

24.29 USD

P/E Ratio

Dividend Yield

Financials AXGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+187 338 000 USD

Last Year

+159 012 000 USD

Current Quarter

+48 560 000 USD

Last Quarter

+49 405 000 USD

Current Year

+141 977 000 USD

Last Year

+127 874 000 USD

Current Quarter

+34 933 000 USD

Last Quarter

+37 575 000 USD
EBITDA 6 559 000 USD
Operating Margin TTM -3.42 %
Price to Earnings
Return On Assets TTM -0.13 %
PEG Ratio
Return On Equity TTM -7.22 %
Wall Street Target Price 24.29 USD
Revenue TTM 194 520 000 USD
Book Value 2.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17.40 %
Dividend Yield
Gross Profit TTM 144 290 000 USD
Earnings per share -0.16 USD
Diluted Eps TTM -0.16 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -3.68 %

Stock Valuation AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 43.48
Enterprise Value Revenue 2.99
Price Sales TTM 2.89
Enterprise Value EBITDA 66.22
Price Book MRQ 5.08

Technical Indicators AXGN

For 52 Weeks

7.34 USD 21.00 USD
50 Day MA 11.69 USD
Shares Short Prior Month 2 267 132
200 Day MA 14.90 USD
Short Ratio 3.72
Shares Short 2 692 243
Short Percent 5.12 %